MAF and Miyoshi myopathy: Overexpression of c-Maf has been regarded as a key factor in MM pathophysiology because interference with c-Maf blocks MM tumor growth in immunodeficient mice [10], while c-Maf-transgenic mice develop MM-like symptoms at old age around 50–60 weeks old [11].